accountReuters -- U.S. regulators are investigating potential risks from Abbott Laboratories Inc's (ABT.N) HIV drug Kaletra, GlaxoSmithKline Plc's (GSK.L)...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to US FDA Probes Risks of HIV, Prostate, Other Drugs; Abbott...
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account